secwatch.observer — SEC 8-K summary
======================================

Issuer:     Anebulo Pharmaceuticals, Inc. (ANEB)
CIK:        0001815974
Form:       8-K
Filed at:   2025-04-15T23:59:59+00:00
Accession:  0001641172-25-004799
Event type: regulatory
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Anebulo regains Nasdaq compliance on private placement share restrictions
-------------------------------------------------------------------------

- Nasdaq confirmed compliance with Listing Rule 5635(b) on April 11, 2025.
- Removal of voting and transfer restrictions on shares issued in December 2024 private placement was approved by stockholders.
- Matter is now closed; no further delisting risk from this issue.
- Company disclosed the resolution in an 8-K filed April 15, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1815974/000164117225004799/0001641172-25-004799-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1815974/000164117225004799/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-004799

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer